U.S. Neurovascular Devices Market to Reach $1.07 Bn, by 2027 at 3.8% CAGR: Allied Market Research

U.S. Neurovascular Devices Market to Reach $1.07 Bn, by 2027 at 3.8% CAGR: Allied Market Research

Growth in prevalence of neurovascular diseases, rise in geriatric population across the U.S., technological developments associated with neurovascular devices, and increase in incidence of underlying disease conditions drive the U.S. Neurovascular Devices market.

PR Newswire

PORTLAND, Ore., Feb. 17, 2021

PORTLAND, Ore., Feb. 17, 2021 /PRNewswire/ -- Allied Market Research published a report, titled, "U.S. Neurovascular Devices Market by Product (Embolization Devices, Revascularization Devices, Thrombectomy Devices, Embolic Protection Devices, and Accessory Devices), and Disease Pathology (Aneurysm, Arteriovenous Malformation, Ischemic stroke, Stenosis, and Others): Opportunity Analysis and Industry Forecast, 2020–2027." According to the report, the U.S. neurovascular devices industry generated $946.15 million in 2019, and is expected to reach $1.07 billion by 2027, manifesting a CAGR of 3.8% from 2020 to 2027.

Allied Market Research Logo

Drivers, restraints, and opportunities

Growth in prevalence of neurovascular diseases, rise in geriatric population across the U.S., technological developments associated with neurovascular devices, and increase in incidence of underlying disease conditions drive the U.S. Neurovascular Devices market. However, higher prices of neurovascular devices hinder the market growth. On the other hand, rise in demand for minimally invasive procedures in U.S. presents new opportunities in the coming years.

Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/9050

Covid-19 Scenario

The embolization devices segment to maintain its lead position during the forecast period

Based on form, the embolization devices segment accounted for more than two-fifths of the U.S. neurovascular devices market in 2019, and is estimated to maintain its lead position during the forecast period. This is attributed to increase in prevalence of neurovascular diseases, introduction of technologically advanced products, rise in R&D investment, surge in geriatric population, increase in adoption of embolization devices, and surge in launch of new and advanced neurovascular devices. However, the revascularization devices segment is projected to witness the highest CAGR of 5.4% from 2020 to 2027, owing to surge in prevalence of cerebral stenosis and brain aneurysm.

The aneurysm segment to maintain its leadership status by 2027

Based on disease pathology, the aneurysm segment contributed to nearly half of the U.S. Neurovascular Devices market in 2019, and is projected to maintain its leadership status in terms of revenue throughout the forecast period. This is attributed to surge in prevalence of the aneurysm, increase in demand for minimally invasive neurosurgical procedures, government initiatives to modernize healthcare infrastructure, technological advancement in neurovascular treatments, and increase in product approvals of new devices used in the treatment of aneurysm. However, the ischemic stroke segment is estimated to manifest the fastest CAGR of 5.9% from 2020 to 2027. The neurovascular device is used in revascularization among patients with acute ischemic stroke and secondary to intracranial large vessel occlusive disease. This augments the growth of the segment.

For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/9050

Leading market players

Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Avenue Library Subscription | Request for 14 days free trial of before buying: https://www.alliedmarketresearch.com/avenue/trial/starter

Get more information: https://www.alliedmarketresearch.com/library-access

Similar Reports:

 Neurosurgery Devices Market - Global Opportunity Analysis and Industry Forecast, 2017-2028

Deep Brain Stimulation Devices Market - Global Opportunity Analysis and Industry Forecast, 2017-2028

Neurological Biomarkers Market- Global Opportunity Analysis and Industry Forecast, 2017-2028

About Us:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research

Logo: https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg  

Voltar noticias em Inglês